MN-25

MN-25 is a synthetic opioid that was first synthesized in the 1990s by a team at Purdue University. It is an analgesic drug that is used in the treatment of severe pain, and it is also used in research. MN-25 is a derivative of fentanyl, which is a powerful opioid that is used in medical settings for pain relief.

History

MN-25 was first synthesized in the 1990s by a team at Purdue University. The team was led by Richard B. Rothman, who is a renowned researcher in the field of pharmacology. The drug was developed as part of a research project that aimed to create new analgesic drugs that could be used in the treatment of severe pain.

Pharmacology

MN-25 is a synthetic opioid, which means that it is a man-made drug that mimics the effects of natural opioids. It works by binding to the mu-opioid receptor in the brain, which is the same receptor that is targeted by drugs like morphine and heroin. When MN-25 binds to this receptor, it triggers a series of chemical reactions that result in pain relief.

Medical uses

MN-25 is used in the treatment of severe pain. It is often used in situations where other pain relief methods have been ineffective. Because of its potency, it is typically only used under the supervision of a healthcare professional.

Research uses

In addition to its medical uses, MN-25 is also used in research. Scientists use it to study the effects of opioids on the brain and to develop new treatments for pain.

See also

• Fentanyl
• Opioid
• Analgesic
• Richard B. Rothman

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia